Different Effects of Thiazolidinediones on Cardiovascular Risk in Patients with Type 2 Diabetes Mellitus: Pioglitazone vs Rosiglitazone

Publisher: Bentham Science Publishers

E-ISSN: 2212-3911|5|3|234-244

ISSN: 1574-8863

Source: Current Drug Safety, Vol.5, Iss.3, 2010-07, pp. : 234-244

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract